Euronext publishes third quarter 2017 results

Euronext publishes third quarter 2017 results

Euronext publishes third quarter 2017 results

The FINANCIAL -- On November 8 Euronext announced its results for the third quarter of 2017.

Strong revenue growth in Q3 2017, up +14.1% compared to Q3 2016, to €128.7m, mainly due to:

Improvement of volumes in a stabilised macro environment:

Cash average daily volume (ADV) up +19.5% in Q3 2017 compared to Q3 2016, to €6.9bn

Market share of cash equities strengthened to 65.2%, with robust yield

Improved competitive landscape for Dutch derivatives with equity derivatives ADV up +20.8%

Strong listing activity over the quarter, with increases in IPO (+68.6%) and follow-on (+38.2%) revenue

Deployment of Agility for Growth initiatives (€2.9m of revenue): development of Corporate Services activity through the acquisition of iBabs in July 2017

Positive impact of the acquisition of FastMatch (€2.9m of revenue), with spot FX ADV up +49.5% to $18.3bn

Cumulated costs savings since 1 April 2016 of €11.9m at the end of Q3 2017, slightly down compared to Q2 2017 due to the costs related to Optiq and MiFID II projects

Growth of EBITDA, up +13.3%, to €69.5m (EBITDA margin of 53.9%, -0.5 points vs. Q3 2016)

Net profit stable (+0.6%) at €38.3m, with good operating performance offset by exceptional items of -€9.7m, mainly related to break-up fee, one-off pension costs and advisory costs

Signing of a 10-year agreement with LCH SA for financial and commodities derivatives clearing, and the swap of a 2.3% minority stake in LCH Group with a 11.1% stake with a pre-emption right[3] in LCH SA (to be closed in the next few months)

Stéphane Boujnah, CEO and Chairman of the Managing Board of Euronext NV., said:

“Euronext’s results for the third quarter of 2017 were driven by the improvement of volume in a stabilised macro environment and by the first contributions of our new acquisitions. We ensured a +13.3% growth in EBITDA this quarter, while we pursued major projects such as MiFID II and Optiq®. This quarter was marked by the deployment of our Agility for Growth strategic plan, through the acquisition of iBabs in July, and by the closing of the acquisition of FastMatch in August. Another major milestone was met in August when we secured the renewal of a 10-year agreement for derivatives clearing with LCH SA, as well as a 11.1% stake and a pre-emption right in this company, ensuring a long-term and improved value proposition for our customers and investors.”